Tag: Acuitas Therapeutics

Cell and Gene Therapy, Industry

Bayer strengthens gene therapy portfolio with lipid nanoparticle technology from Acuitas Therapeutics

June 7, 2023

Via: World Pharma News

Bayer AG is joining forces with Acuitas Therapeutics, Inc., a biotechnology company specializing in the development of lipid nanoparticle (LNP) delivery systems for molecular therapeutics. Acuitas’ LNP technology will support Bayer’s in vivo gene editing and protein replacement programs by […]

Mergers and Acquisitions

Pfizer and Acuitas Therapeutics Collaborate on Lipid Nanoparticle Delivery System

January 11, 2022

Via: Biopharm International

Pfizer and Acuitas Therapeutics, a company focused on developing lipid nanoparticle (LNP) delivery systems to enable messenger RNA (mRNA)-based therapeutics, have entered into a development and option agreement under which Pfizer will have the option to license, on a non-exclusive […]